Lataa...
Dapagliflozin: an effective adjunctive treatment in type 1 diabetes
INTRODUCTION: Many people with type 1 diabetes (T1DM) continue to run high HbA1c levels with an associated elevated risk of cardiovascular events and increased mortality. We describe here how adjunctive prescription of an SGLT2 inhibitor has improved the glycaemic control of several people with T1DM...
Tallennettuna:
| Julkaisussa: | Cardiovasc Endocrinol Metab |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wolters Kluwer Health
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8189611/ https://ncbi.nlm.nih.gov/pubmed/34124604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/XCE.0000000000000248 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|